Budget impact analysis of cenobamate, a novel adjunctive therapy for the treatment of drug resistant focal onset seizures, from the Belgian healthcare payer perspective.
Saved in:
| Title: | Budget impact analysis of cenobamate, a novel adjunctive therapy for the treatment of drug resistant focal onset seizures, from the Belgian healthcare payer perspective. |
|---|---|
| Authors: | Vonck K; Department Neurology - 4Brain, Ghent University Hospital, Ghent, Belgium., Bodart O; Neurology Department, University Hospital of Liège, Liège, Belgium., Weckhuysen S; Neurology Department, University Hospital Antwerp, Antwerp, Belgium., Tanghe A; Hict NV, Ghent, Belgium., Callebaut B; Hict NV, Ghent, Belgium., Verdonck C; Hict NV, Ghent, Belgium., Van den Bergh L; Angelini Pharma, Paris, France., Legros B; Neurology Department, HUB-Hôpital Erasme, Brussels, Belgium. |
| Source: | Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 990-1001. Date of Electronic Publication: 2025 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1941-837X |
|---|---|
| DOI: | 10.1080/13696998.2025.2520182 |
